EMA Authorised: GONAL-f (follitropin alfa) — Merck Europe B.V.

View source ↗

Summary

The European Medicines Agency authorised GONAL-f (follitropin alfa) by Merck Europe B.V. for indications including Anovulation, infertility, and hypogonadism, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation
• Hypogonadism
• Infertility

Drugs mentioned

• Gonal-F (follitropin alfa)

Snippet

Status: Authorised. Therapeutic area: Anovulation;Reproductive Techniques, Assisted;Infertility, Female;Hypogonadism. MAH: Merck Europe B.V.. Decision date: 06/01/2025